Date: April 9-10, 2015
Venue: Hotel Westin, Mumbai
Organiser: Alliance India
Summary: Asia has a population of around 4.3 billion and is home to about 60 per cent of the world’s population. China alone has a population of approximately 1.3 billion, which is three- to fourfold bigger than Europe or the US. Adding in the other developing markets, such as those in Latin America, this makes for a huge potential market for the pharmaceutical industry, and one important not to miss.
The growth markets popularly include Brazil, Russia, India, China – the BRICs however Mexico, South Korea, and Turkey are now added to BRICs to be known as the BRIC-MST countries. In terms of the submission format, countries are beginning to move closer to the international submission template (eCTD — electronic common technical document). Similarly, the trend is toward more harmonisation in legal frameworks among the countries. For example, China’s regulatory processes are evolving, creating a framework that is more closely aligned to the US and European legislation and in both South Korea and China, the regulatory agency has been raised to the ministry level.
Contact Details:
Mob: +91 9619633320
Email: [email protected]
Comments are closed.